The global pharmaceutical
market was estimated at USD 1.11 trillion in 2017 and projected to reach USD
1.43 trillion by 2020. In 2017, North America, Asia Pacific and Western Europe
pharmaceutical market approximately accounted for 37%, 22% and 20% global
market share respectively.
In 2017, top-10 global pharmaceutical
companies generated sales of USD 437.257 billion accounting for roughly 40%
global market share and top-15 global pharmaceutical companies generated sales
of USD 568.617 billion accounting for 51% global market share. A comparative
analysis of the top-15 organizations was used to develop a ranking for these
companies.
The ranking model incorporated
seven criteria for each organization with focus on revenues generated by
pharmaceutical products and growth in pharmaceutical revenues (2016 – 2017).
The criteria includes pharmaceutical revenues, annual pharmaceutical revenue
growth, total R&D expense, total expense, total income, proportion of
revenue from top three pharmaceutical products and revenue per employee. A
score statistic was developed based on these selected criteria. Each company
was assigned a score for each criteria and a weighted sum was used to arrive at
the final score statistic. Pharmaceutical revenue received the highest weight
(45%) while revenue from top 3 products (5%) receives the lowest. The score
statistic represented the pharmaceutical financial health and diversity of
product portfolio of each company.
F. Hoffmann-La Roche Ltd (Switzerland)
Hoffmann-La Roche (Roche) is a
research-focused healthcare company that develops, manufactures and delivers
innovative therapeutics and diagnostic instruments and tests. Roche offers
medicine in oncology, diabetes, ophthalmology, neuroscience, immunology, and
infectious diseases. In 2017, top 3 best-selling drugs include cancer
treatments MabThera/Rituxan, Herceptin, and Perjeta.
Pfizer (U.S.)
Pfizer is a research-based
pharmaceutical company engaged in the wellness, prevention and treatment for
diseases across a broad range of therapeutic areas. The company operates
through Innovative Health and Established Health business segments. Pfizer
offers medicine in cardiology, oncology, and immunology. In 2017, top 3
best-selling drugs include Lyrica, Prevnar 13/Prevenar 13, and Ibrance.
AbbVie (U.S.)
AbbVie, is a research-based
biopharmaceutical company that develops and markets advanced therapies focused
on treating rheumatology, gastroenterology, dermatology, oncology, virology,
neurological disorders and other metabolic related and critical conditions. In
2017, top 3 best-selling drugs include Humira, Imbruvica, and HCV.
Johnson & Johnson (U.S.)
Johnson & Johnson
(J&J) is a pharmaceutical and consumer goods manufacturing companies and
its subsidiaries are engaged in the research, development, manufacturing and
selling of pharmaceuticals, medical devices and consumer health products.
Johnson & Johnson offers medicine in Hepatitis C, HIV/AIDS, Arthritis, and
digestive conditions. In 2017, top 3 best-selling drugs include Remicade,
Stelara, and Invega Sustenna / Xeplion / Trinza / Trevicta.
Sanofi (France)
Sanofi is a French
pharmaceutical company involved in research, development, manufacturing and
marketing of therapeutic solutions. Sanofi offer medicines in prescription and
over the counter (OTC) categories having major drugs in central nervous system,
cardiovascular, oncology, diabetes, internal medicine, and vaccines. In 2017,
top 3 best-selling drugs include Lantus, Lovenox, and Aubagio.
Merck & Co. (U.S.)
Merck, research and
development company, known as MSD outside the United States and Canada, offers
health solutions through its prescription medicines, vaccines, biologic
therapies and animal health products. Merck offers medicines in oncology,
fertility, neurodegenerative diseases, and endocrinology. In 2017, top 3
best-selling drugs include Januvia / Janumet, Keytruda, and Gardasil / Gardasil
9.
Novartis (Switzerland)
Novartis is a global
healthcare company based in Basel, Switzerland. The company’s portfolio
includes innovative biological therapies and pharmaceuticals in several disease
areas including oncology, cardiology, neurology, immunology, eye care, generic
and bio-similar medicines. In 2017, top 3 best-selling drugs include Gilenya,
Cosentyx, and Glivec.
Gilead Sciences (U.S.)
Gilead is a research-based
biopharmaceutical company that discovers, develops and commercializes
innovative medicines. Gilead Sciences focused on virology, hepatology,
hematology, oncology, cardiovascular, inflammation and respiratory diseases. In
2017, top 3 best-selling drugs include Harvoni, Epclusa, and Truvada.
GlaxoSmithKline (U.K.)
GlaxoSmithKline is
research-focused pharmaceutical company engaged in discovering, manufacturing
and distributing pharmaceutical products including prescription
medicines, vaccines and consumer healthcare. It offers medicines in
cardiovascular disease, gynecology, diabetes, anti-infective, dermatology, and
respiratory diseases. In 2017, top 3 best-selling drugs include
Seretide/Advair, Triumeq, and Tivicay.
Amgen (U.S.)
Amgen Inc. is an American
multinational biopharmaceutical company headquartered in Thousand Oaks,
California that discovers and develops innovative therapies in both
biopharmaceuticals and small molecule drugs. In 2017, top 3 best-selling drugs
include Enbrel, Neulasta, and Aranesp.
